Follow Elekta

Visit Elekta.com

Elekta | Focus Magazine

How evidence and trust helped Pepi make the best choices

“This is bad, isn’t it,” Pepi recounts telling the clinician when receiving the results of her mammogram. She says she already knew the outcome. “I’d previously been treated for another tumor and knew something could be malignant. So, I almost diagnosed myself actually.” Sadly, she was right. The tumor in her breast was cancerous, but…

Leaving cervical cancer nowhere to hide

Suryavathi Kanda, 39, and her family, consisting of her husband and now young adult children, run a small dairy business in Andhra Pradesh, India. It is hard work, so when Suryavathi learned that she had cervical cancer, she immediately started to worry. What would happen to the family business if she could not work? And…

Australian cervical cancer patients benefit from clinic’s latest Elekta GYN applicator

Olivia Newton-John Cancer Wellness and Research Centre (ONJ, Melbourne, Victoria) clinicians began using their new Geneva™ Universal Gynecological Applicator in October 2020 and in a very short time it became the clinic’s preferred applicator for patients with cervical cancer – accounting for three out of every four treatments. According to ONJ radiation oncologist Dr. Carminia…

Optimizing needle insertion with CT guidance during GYN brachytherapy

Using CT to guide and plan intracavitary/interstitial brachytherapy for patients with cervical cancer is an attractive option for centers with limited 3D imaging options for determining needle use and location, a recent study asserts.1 Whether done with or without image guidance, it is reported that adding needles to intracavitary brachytherapy significantly increased the three-year local…

Clinic’s new GYN applicator boosts cervical cancer brachytherapy capabilities

Clinicians at Leiden University Medical Center (LUMC, Leiden, The Netherlands) recently began using their new Geneva applicator for patients with cervical cancer up to stage IIB, which represents the majority of patients worldwide with locally advanced disease. Geneva – with its variety of ovoid sizes and interstitial needle positions, as well as several other features…

Conserving the future quality of life for the youngest cancer patients

While it is an exceptionally rare cancer with an incidence of just four cases per one million children two to three years of age, embryonal rhabdomyosarcoma (RMS, see sidebar) presents difficult treatment challenges, particularly when the disease impacts the patient’s bladder and reproductive organs. Radical surgery that removes the bladder and/or external beam radiation therapy…

Elekta template helps Morocco clinic boost prostate brachytherapy success

Because a potent, targeted post-EBRT boost of high dose rate (HDR) brachytherapy has been shown to result in a higher prostate cancer control rate than EBRT alone,1-3 the technique has earned an important place in the treatment of eligible high and intermediate-risk patients. Clinicians at Clinique Spécialisée Menara (Marrakesh, Morocco) began treating these patients with…

UK center continues brachytherapy evolution with Elekta’s Venezia applicator

Thanks to the UK National Health Service’s extensive screening programs for cervical cancer, the country’s incidence of advanced cases is relatively low—most brachytherapy centers will have a suitable applicator for the majority of cervical cancer patients needing treatment. But for patients whose cancer has spread to the parametrium and beyond, gynecological brachytherapy applicators that enable…